Loading...

POAI PREDICTIVE ONCOLOGY INC Management Changes 8-K Filing

PRDC

P

PREDICTIVE ONCOLOGY INC

(POAI)

2025 8-K

Summary

Summary

Private Placement Announcement

Private Placement Announcement

Private Placements Announced

Stock Split Approved

Stock Awards Granted

Stock Sale Agreement

Financial Results Update

Delisting due to Non-Compli...

Divestment of Assets

Delisting due to Non-Compli...

Equity Offerings

Voluntary Delisting

Equity Offerings

Financial Statements

Merger Discussions Ended

Financial Results

Acquisition Update

Annual Meeting Results

Acquisition Agreement

Nasdaq Compliance Notice

Financial Results

Nasdaq Compliance Notice

Financial Results

Agreement with Warrant Holders

Financial Results Announcement

Accounting Firm Engagement ...

Financial Results Announcement

Disclosure of Say-on-Pay Vo...

Departure of Chief Business...

Annual Meeting of Stockholders

Financial Results Announcement

Management Change

Earnings Reports

Financial Results Announcement

Compliance Regained

Management Changes

Reverse Stock Split

Dismissal of Independent Re...

Financial Results Announcement

Dividend Declaration

Investor Relations Engagement

Warrant Agent Appointment

Appointment of Chief Busine...

External Links:

On September 9, 2025, Predictive Oncology Inc. awarded 124,959 restricted stock units (RSUs) to CEO Raymond F. Vennare and 97,000 RSUs to Interim CFO Josh Blacher, which will vest on October 31, 2025.

AI Assistant

PREDICTIVE ONCOLOGY INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.